Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Aristotle University Of Thessaloniki |
---|---|
Information provided by: | Aristotle University Of Thessaloniki |
ClinicalTrials.gov Identifier: | NCT00331240 |
The purpose of this study is to compare the short-term (8 week) mean 24-hour IOP control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.
Condition | Intervention | Phase |
---|---|---|
Primary Open Angle Glaucoma Exfoliation Syndrome |
Drug: travoprost/timolol fixed combination Drug: placebo (artificial tears) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment |
Ages Eligible for Study: | 29 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Greece | |
Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital | |
Thessaloniki, Greece, 546 36 |
Principal Investigator: | AGP Konstas, MD, PhD | Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital |
Study ID Numbers: | A1457 |
Study First Received: | May 26, 2006 |
Last Updated: | September 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00331240 |
Health Authority: | Greece: National Organization of Medicines |
Glaucoma Eye Diseases Glaucoma, Open-Angle Exfoliation Syndrome |
Timolol Travoprost Hypertension Ocular Hypertension |
Uveal Diseases Neurotransmitter Agents Disease Adrenergic Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Cardiovascular Agents Antihypertensive Agents |
Pharmacologic Actions Pathologic Processes Iris Diseases Therapeutic Uses Syndrome Adrenergic beta-Antagonists Adrenergic Antagonists Anti-Arrhythmia Agents |